Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PEGCETACOPLAN vs ZILUCOPLAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

PEGCETACOPLAN vs ZILUCOPLAN: Safety Overview

Metric PEGCETACOPLAN ZILUCOPLAN
Total FAERS Reports 1,369 441
Deaths Reported 84 23
Death Rate 6.1% 5.2%
Hospitalizations 252 163
Average Patient Age 65.4 yrs 58.8 yrs
% Female Patients 70.5% 53.6%
FDA Approval Date Feb 17, 2023 Oct 17, 2023
Manufacturer Apellis Pharmaceuticals, Inc. UCB, Inc.
Route SUBCUTANEOUS SUBCUTANEOUS
Marketing Status Prescription Prescription